Published in Virology on April 15, 1984
The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic. Proc Natl Acad Sci U S A (2002) 2.39
Adaptation of pandemic H1N1 influenza viruses in mice. J Virol (2010) 2.22
Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc Natl Acad Sci U S A (1990) 2.08
Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8. J Virol (1990) 1.84
Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection. PLoS Pathog (2009) 1.24
A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence. Virology (2005) 1.09
Protection against divergent influenza H1N1 virus by a centralized influenza hemagglutinin. PLoS One (2011) 0.87
Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency. PLoS One (2008) 0.84
Adaption of seasonal H1N1 influenza virus in mice. PLoS One (2011) 0.82
Low seroprevalent species D adenovirus vectors as influenza vaccines. PLoS One (2013) 0.81
The significance of avian influenza virus mouse-adaptation and its application in characterizing the efficacy of new vaccines and therapeutic agents. Clin Exp Vaccine Res (2017) 0.75
An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus. Acta Virol (1999) 2.06
Transmission of Eurasian avian H2 influenza virus to shorebirds in North America. J Gen Virol (1999) 1.85
Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region. Arch Virol (2000) 1.61
Incorporation of influenza virus M-protein into liposomes. J Virol (1980) 1.61
Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs. Virology (1998) 1.60
Integration of viral genomes. Nature (1975) 1.45
Postreassortment changes in influenza A virus hemagglutinin restoring HA-NA functional match. Virology (1998) 1.42
Return of epidemic A1 (H1N1) influenza virus. Lancet (1978) 1.38
Comparison of influenza viruses isolated from man and from whales. Bull World Health Organ (1978) 1.34
Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J Infect Dis (1995) 1.26
Phenotypic expression of HA-NA combinations in human-avian influenza A virus reassortants. Arch Virol (1996) 1.20
Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes. Virus Res (2000) 1.19
A quantitative estimation of poxvirus genome fraction transcribed as "early" and "late" mRNA. Virology (1975) 1.16
Infectious DNA of tick-borne encephalitis virus. Arch Gesamte Virusforsch (1974) 1.15
Combined inhibition of influenza virus reproduction in cell culture using interferon and amantadine. Nature (1968) 1.15
Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. J Gen Virol (1986) 1.14
Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol (2005) 1.11
The genetic aspects of influenza virus filamentous particle formation. Arch Virol (1991) 1.10
Integration of measles virus nucleic acid into the cell genome. Arch Gesamte Virusforsch (1974) 1.08
Morphogenesis of Venezuelan equine encephalomyelitis virus. J Virol (1969) 1.06
Combined action of ribovirin and rimantadine in experimental myxovirus infection. Experientia (1977) 1.05
Mason-Pfizer virus characterization: a similar virus in a human amniotic cell line. J Virol (1973) 1.03
Newcastle disease virus-specific RNA: polyacrylamide gel analysis of single-stranded RNA and hybrid duplexes. J Virol (1974) 1.03
Newcastle disease virus-specific RNA: an analysis of 24 S and 35 S RNA transcripts. Acta Virol (1979) 1.03
Widespread distribution and high prevalence of an alpha-proteobacterial symbiont in the tick Ixodes ricinus. Environ Microbiol (2006) 1.02
Studies on heterotypic interference between influenza A and B viruses: a differential inhibition of the synthesis of viral proteins and RNAs. J Gen Virol (1983) 1.02
Influenza A virus reassortants with surface glycoprotein genes of the avian parent viruses: effects of HA and NA gene combinations on virus aggregation. Arch Virol (1993) 0.99
Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host. Acta Virol (2000) 0.98
Studies on the genetic basis of human influenza A virus adaptation to mice: degrees of virulence of reassortants with defined genetic content. Arch Virol (1989) 0.97
Influence of PPLO on production of interferon in virus-infected cells. Virology (1965) 0.97
On the origin of the H1N1 (A/USSR/90/77) influenza virus. J Gen Virol (1981) 0.97
Architecture of Venezuelan equine encephalomyelitis virus. Virology (1965) 0.96
The 1967 outbreak of influenza B in the U.S.S. R. Lancet (1967) 0.96
Receptor specificity of H5 influenza virus escape mutants. Virus Res (2004) 0.96
Studies on the genetic determinants of influenza virus pathogenicity for mice with the use of reassortants between mouse-adapted and non-adapted variants of the same virus strain. Arch Virol (1986) 0.93
The 1965 influenza A2 epidemic in the USSR and antigenic analysis of isolated strains. Am J Epidemiol (1967) 0.93
HeLa-like marker chromosomes and type-A variant glucose-6-phosphate dehydrogenase isoenzyme in human cell cultures producing Mason-Pfizer monkey virus-like particles. J Natl Cancer Inst (1974) 0.92
Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants. Arch Virol (2007) 0.92
Delay in the incorporation of protein into virus nucleocapsid in Newcastle disease virus infected cells. J Gen Virol (1972) 0.92
Biophysical characteristics of respiratory syncytial virus. Rev Roum Virol (1974) 0.92
Use of iodinized antibody for revealing viral antigens in ultra-thin sections of cells. Nature (1965) 0.91
[Characteristics of the molecular organization of bacteriophage T4 whiskers]. Dokl Akad Nauk SSSR (1987) 0.91
Transcription of both DNA strands of vaccinia virus genome in vivo. Virology (1979) 0.89
Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus. Acta Naturae (2010) 0.88
Newcastle disease virus-specific RNA: hybridization-competition of the non-dissociable 35 S RNA with individual 18 S RNA species. Acta Virol (1979) 0.88
Synthesis and transport of protein components of Sendai Virus. Arch Gesamte Virusforsch (1965) 0.87
Cross-protection and reassortment studies with avian H2 influenza viruses. Arch Virol (2000) 0.87
Isolation of oncornaviruses from continuous human cell cultures. Intervirology (1973) 0.86
Ribonucleic acids synthesized in Venezuelan equine encephalomyelitis virus-infected cells. Virology (1969) 0.86
Postreassortment changes in a model system: HA-NA adjustment in an H3N2 avian-human reassortant influenza virus. Arch Virol (2005) 0.86
Transient disulfide bonds formation in conformational maturation of influenza virus nucleocapsid protein (NP). Virus Res (2004) 0.86
[Replicative intermediate form of RNA in cells infected with Newcastle disease virus (NDV)]. Vopr Virusol (1972) 0.86
[Evolution of avian influenza viruses H5N1 (1997-2004) in southern and south-eastern Asia]. Vopr Virusol (2005) 0.85
Gradual changes of influenza virions during passage of undiluted material. J Gen Virol (1980) 0.85
Molecular pathogenesis of systemic lupus erythematosus. Arch Virol (1975) 0.85
Synthesis of components of Sendai virus in the presence of proflavine. J Immunol (1965) 0.85
An unusual influenza situation in 1977-78. WHO Chron (1978) 0.85
Disulfide bonding in influenza virus proteins as revealed by polyacrylamide gel electrophoresis. J Virol (1982) 0.85
Formation of mixed hemagglutinin trimers in the course of double infection with influenza viruses belonging to different subtypes. Virus Res (1988) 0.85
[The characteristics of the long-term continuous cultivation of a cell line chronically infected with the human immunodeficiency virus type-1]. Vopr Virusol (1992) 0.84
Deviation from the random distribution pattern of influenza A virus gene segments in reassortants produced under non-selective conditions. Arch Virol (2008) 0.84
Relationship between group A arbovirus reproduction and cytochemical changes in infected cells. Acta Virol (1968) 0.84
Additive effect of histones and actinomycin D on the cellular RNA synthesis. Exp Cell Res (1966) 0.84
An oncornavirus isolated from human cancer cell line. Cancer (1973) 0.84
[The primary structure of the hemagglutinin of influenza A (H3N2) viruses isolated in the USSR in 1985]. Vopr Virusol (1989) 0.83
Influenza virus antigens conjugated with a synthetic polyelectrolyte: a novel model of vaccines. Vaccine (1985) 0.83
B-type oncornaviruses isolated from continuous human cancer cell lines. Arch Gesamte Virusforsch (1973) 0.83
[Use of leukocyte cultures for studying cytomegalovirus infection in man]. Vopr Virusol (1969) 0.83
[Integration of the genomes of the tick-borne encephalitis virus and of the cell in chronic infection due to this virus and SV40]. Dokl Akad Nauk SSSR (1981) 0.82
Human-avian influenza virus reassortants: effect of reassortment pattern on multi-cycle reproduction in MDCK cells. Arch Virol (1988) 0.82
Action of proflavine on the development of Sendai virus in HEp 2 cells. Br J Exp Pathol (1966) 0.82
Prevention and treatment of lethal influenza A virus bronchopneumonia in mice by monoclonal antibody against haemagglutinin stem region. Acta Virol (1997) 0.82
Interaction of influenza virus proteins with planar bilayer lipid membranes. I. Characterization of their adsorption and incorporation into lipid bilayers. Biochim Biophys Acta (1984) 0.82
Results of a two-year study of humoral immunity to influenza A and B viruses in children under the age of 14 years in Moscow and its suburbs. Bull World Health Organ (1984) 0.81
New possibilities of investigating nucleic acids and nucleoproteins in aqueous solutions by infrared spectroscopy. Nature (1972) 0.81
[The use of polyacrylamide gels in the study of Newcastle disease virus RNA]. Vopr Virusol (1969) 0.81
Isolation of a natural recombinant of influenza A virus (H1N3) from a sick child. Lancet (1983) 0.81
Topography and dynamics of synthesis of structural proteins of Newcastle disease virus. J Bacteriol (1966) 0.81
[Intermolecular covalent (disulfide) bonds in the peplomers of influenza virus hemagglutinin]. Vopr Virusol (1983) 0.81
Interaction of influenza virus proteins with planar lipid bilayers: a model for virion assembly. Biochem Biophys Res Commun (1981) 0.81
The role of carbohydrate in determining the immunochemical properties of the hemagglutinin of influenza A virus. Arch Virol (1981) 0.81
Antigenic determinants in influenza virus hemagglutinin. Infect Immun (1979) 0.81
In vitro studies with the scrapie agent. Acta Virol (1985) 0.81
The use of antibody labeled with an organic mercury compound in electron microscopy. J Histochem Cytochem (1966) 0.80
Persistent SV5 virus infection in continuous cell cultures. Acta Virol (1976) 0.80
Continuous mouse brain cell lines chronically infected with Japanese encephalitis virus. J Gen Virol (1974) 0.80